USX:CELU - Celularity Inc Celularity Inc
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 8.34    -0.205 (-2.40%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

27 Jul 2021


Loading...
Loading...
Loading...

General

CEO: Dr. Robert Joseph Hariri M.D., Ph.D.

IPO: 2019-08-08

Headquarters: US

Homepage

Description

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.